ASAN FOUNDATION
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Private
- Established
- 1989-06-23
- Employees
- 501
- Market Cap
- -
- Website
- https://ails.amc.seoul.kr
Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer: Zolinza+XP
Phase 1
Completed
- Conditions
- Gastric CancerHistone Deacetylase Inhibitor
- Interventions
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 45
- Registration Number
- NCT01045538
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Donor-specific Allogeneic Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia (ALL)
Phase 2
Terminated
- Conditions
- Acute Lymphoid Leukemia
- Interventions
- Procedure: alloHCT
- First Posted Date
- 2009-12-23
- Last Posted Date
- 2018-07-20
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT01037764
- Locations
- 🇰🇷
Inje University Haeundae Paik Hospital, Pusan, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir
Phase 4
Completed
- Conditions
- Hepatitis B, Chronic
- Interventions
- First Posted Date
- 2009-12-02
- Last Posted Date
- 2014-02-10
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 90
- Registration Number
- NCT01023217
- Locations
- 🇰🇷
Asan Medical Center, Seoul, the Meteropolis of Seoul, Korea, Republic of
Latent Tuberculosis Infection in Bone Marrow Transplant Recipients
Completed
- Conditions
- Tuberculosis
- First Posted Date
- 2009-11-26
- Last Posted Date
- 2013-07-18
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 409
- Registration Number
- NCT01021124
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Donor Stem Cell Transplant or Bone Marrow Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
Phase 2
Completed
- Conditions
- Leukemia
- Interventions
- Biological: anti-thymocyte globulinDrug: busulfanDrug: cyclophosphamideDrug: cyclosporineDrug: fludarabine phosphateDrug: methotrexateProcedure: allogeneic hematopoietic stem cell transplantation
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2015-12-31
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 263
- Registration Number
- NCT01020734
- Locations
- 🇰🇷
Inje University - Haeundae Paik Hospital, Busan, Korea, Republic of
🇰🇷Asan Medical Center - University of Ulsan College of Medicine, Seoul, Korea, Republic of
PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage
Phase 4
- Conditions
- Brain IschemiaIntracranial Hemorrhages
- Interventions
- Drug: CilostazolDrug: ProbucolDrug: AspirinDrug: placebo of aspirinDrug: placebo of cilostazolDevice: ankle-brachial index (ABI)Device: intima-medial thickness (IMT)Device: new asymptomatic brain hemorrhageDevice: new ischemic lesions on follow-up FLAIR images
- First Posted Date
- 2009-11-13
- Last Posted Date
- 2015-12-24
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 1600
- Registration Number
- NCT01013532
- Locations
- 🇰🇷
Korea University Ansan Hospital, Ansan, Gyeonggi-do, Korea, Republic of
🇰🇷Hanyang University Medical Center, Seoul, Korea, Republic of
🇰🇷Wonju Christian Hospital, Wonju, Gangwon-do, Korea, Republic of
The Role of Positron Emission Tomography (PET) During Erlotinib Treatment for Non-small Cell Lung Cancer
- Conditions
- ErlotinibLung Cancer
- First Posted Date
- 2009-10-23
- Last Posted Date
- 2009-10-27
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 34
- Registration Number
- NCT01000428
- Locations
- 🇰🇷
Asan Medical Center, Seoul, SongPa-Gu, Korea, Republic of
Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency
Phase 4
Completed
- Conditions
- Urinary Bladder, OveractiveOveractive Bladder
- Interventions
- First Posted Date
- 2009-09-18
- Last Posted Date
- 2016-02-02
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 291
- Registration Number
- NCT00979472
Adjuvant Chemotherapy With Docetaxel, Capecitabine and Cisplatin in Patients With Advanced Gastric Cancer: Adjuvant DXP
Phase 2
Completed
- Conditions
- Resected Advanced Gastric Cancer
- Interventions
- First Posted Date
- 2009-09-15
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 46
- Registration Number
- NCT00976976
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Songpa-gu, Korea, Republic of
Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin
- First Posted Date
- 2009-09-14
- Last Posted Date
- 2020-01-07
- Lead Sponsor
- Asan Medical Center
- Target Recruit Count
- 44
- Registration Number
- NCT00976768
- Locations
- 🇰🇷
Asan medical center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath